STVN logo

STEVANATO GROUP SPA

STVNNYSE
πŸ† #1208 by market capEarnings Nov 5US Equity
$598.76β–Ό $38.62 (βˆ’6.45%)
Simulated price
πŸ””
Track STVN
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 6.5%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$5.77B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+3.2%
Slowing
πŸ“ŠGross Margin
29.2%
Moderate
πŸ’΅FCF Margin
-2.1%
Thin
βš–οΈP/S Ratio
4.1x
Fair
Otter Score
92
Very Good
No chart data available for STVN.

Trading Snapshot

Day Range
$594.14 – $603.75
52-Week Range
$12.89 – $27.99
Volume
$3.91B
Avg Volume
$4.29B
Shares Outstanding
273.0M
Next Earnings
Nov 11, 2026

Fundamentals Snapshot

Annual Revenue
$1.14B
Last Q Revenue
$302M
P/E Ratio
38.7
P/S Ratio
4.1x
EPS (TTM)
$0.49
Dividend Yield
0.29%
Dilution (1yr)
+0.0%

Why Investors Own STVN

  • βœ“High-growth profile β€” revenue up +57.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 66% gross margin and 11% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

STVN logo

STEVANATO GROUP SPA

STVN
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1.1Bβ–² +3.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
29.0%β–² +5.9% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$183Mβ–² +13.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$21Mβ–Ό βˆ’113.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
273.0Mβ–² +0.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$340Mβ–Ό βˆ’$9M YoY
StockOtter Β· stockotter.space

About STEVANATO GROUP SPA

Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Very Good
92/100

Analyst Price Target

β“˜
Average Target
$780.17
β–² +30.3% Upside
High Target$944.83
Low Target$595.80
Based on 16 analysts

Latest News & Updates